Wiltshire et al., 2000 - Google Patents
Development of a high-performance liquid chromatographic–mass spectrometric assay for the specific and sensitive quantification of Ro 64-0802, an anti-influenza …Wiltshire et al., 2000
- Document ID
- 1467188472907406141
- Author
- Wiltshire H
- Wiltshire B
- Citron A
- Clarke T
- Serpe C
- Gray D
- Herron W
- Publication year
- Publication venue
- Journal of Chromatography B: Biomedical Sciences and Applications
External Links
Snippet
Oseltamivir phosphate (Ro 64-0796/002) is a pro-drug of the anti-influenza neuraminidase inhibitor, Ro 64-0802, and as Tamiflu™, has been developed for the treatment of both A and B strains of the disease. This paper describes an HPLC–MS–MS assay for both compounds …
- 210000002381 Plasma 0 title abstract description 99
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/978—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wiltshire et al. | Development of a high-performance liquid chromatographic–mass spectrometric assay for the specific and sensitive quantification of Ro 64-0802, an anti-influenza drug, and its pro-drug, oseltamivir, in human and animal plasma and urine | |
Calafat et al. | Automated solid phase extraction and quantitative analysis of human milk for 13 phthalate metabolites | |
Jestoi | Emerging Fusarium-mycotoxins fusaproliferin, beauvericin, enniatins, and moniliformin—A review | |
King et al. | Liquid chromatography–tandem mass spectrometric determination of tenofovir-diphosphate in human peripheral blood mononuclear cells | |
US20220187326A1 (en) | Method for the Direct Detection and/or Quantification of at Least One Compound with a Molecular Weight of at Least 200 | |
Zhang et al. | Determination of melamine and cyanuric acid in human urine by a liquid chromatography tandem mass spectrometry | |
De Baere et al. | Quantitative determination of amoxicillin in animal feed using liquid chromatography with tandem mass spectrometric detection | |
Franklin et al. | Improved analytical procedure for the measurement of captopril in human plasma by gas chromatography–mass spectrometry and its application to pharmacokinetic studies | |
Nguyen et al. | Development and validation of a simple, selective, and sensitive LC-MS/MS assay for the quantification of remdesivir in human plasma | |
Bressán et al. | Optimization and validation of a liquid chromatography-tandem mass spectrometry method for the determination of glyphosate in human urine after pre-column derivatization with 9-fluorenylmethoxycarbonyl chloride | |
Paglia et al. | Development and validation of a LC/MS/MS method for simultaneous quantification of oxcarbazepine and its main metabolites in human serum | |
Brum Junior et al. | Determination of quinine and doxycycline in rat plasma by LC–MS–MS: application to a pharmacokinetic study | |
Janicka et al. | Sensitive determination of isoprostanes in exhaled breath condensate samples with use of liquid chromatography–tandem mass spectrometry | |
Cheng et al. | Development and validation of a liquid chromatography/tandem mass spectrometry method for determination of caspofungin in dried blood spots | |
Favreto et al. | Development and validation of a UPLC‐ESI‐MS/MS method for the determination of N‐butylscopolamine in human plasma: Application to a bioequivalence study | |
Guerra Valero et al. | Development and validation of a UHPLC-MS/MS method to measure cefotaxime and metabolite desacetylcefotaxime in blood plasma: a pilot study suitable for capillary microsampling in critically ill children | |
Sharma et al. | A sensitive bioanalytical method for quantitative determination of resiniferatoxin in rat plasma using ultra-high performance liquid chromatography coupled to tandem mass spectrometry and its application in pharmacokinetic study | |
Roseboom et al. | Development and validation of a high-performance liquid chromatography tandem mass spectrometry method for the quantification of the antiparasitic and antifungal drug amphotericin B in human skin tissue | |
Liao et al. | Quantification of adenosine Mono-, Di-and triphosphate from royal jelly using liquid chromatography-Tandem mass spectrometry | |
Luciani-Giacobbe et al. | Validation of a simple isocratic HPLC-UV method for rifampicin and isoniazid quantification in human plasma | |
Aviram et al. | Dried urine spot and dried blood spot sample collection for rapid and sensitive monitoring of exposure to ricin and abrin by LC–MS/MS analysis of ricinine and l-abrine | |
Andonie et al. | Simultaneous determination of carbamazepine and carbamazepine-10, 11-epoxide in different biological matrices by LC-MS/MS | |
Zhang et al. | High-performance liquid chromatography–atmospheric pressure chemical ionisation-mass spectrometry determination of zaleplon in human plasma | |
Zhurkovich et al. | Determination of buprenorphine and naloxone in patient blood plasma using HPLC-MS | |
Wang et al. | Advancing towards practice: A novel LC-MS/MS method for detecting retinol in dried blood spots |